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RL388 monoclonal antibodies in human [13,14] and rodent Abstract Galectin-3, a mammalian galaetoside-binding protein, 
is not expressed in the Jurkat T-lymphoblastoid cell line. [15,16] cells, respectively. CD98 antigen is expressed on most 
However, Jurkat cells express surface glycoprotein receptors cell lines in culture as well as on monocytic ells. Interestingly, 
for galectin-3, one of which is shown to be the glycosylated heavy CD98 is also expressed on activated human lymphocytes 
chain of CD98 (4F2 antigen), a T-cell activation marker, although not on resting T and B lymphocytes. Although pre- 
Addition of galectin-3 to Jurkat cells triggers a sustained influx l iminary evidence [17] suggests that lymphocytes do not ex- 
of extracellular Ca 2+ in a concentration dependent manner. The press galectin-3, we were prompted by these findings to exam- 
induced increase in eytosollc [Ca2+]i is blocked by sugar hapten ine whether lymphocytes bind exogenous lectin. In this report, 
inhibitors of galectin-3. The galectin-3-induced effect is insensi- we show that exogenous galectin-3 binds to surface glycopro- 
tire to voltage-gated Ca 2+ channel antagonists such as teins, including CD98, of the human lymphoblastoid Jurkat 
prenylamlne, nifedipine and diltiazem and to pertussis toxin but T-cell line. Furthermore, surface ligation of these cells triggers 
is inhibited by cholera toxin. The results suggest hat galectin-3 
released by accessory cells such as macrophages may bind in vivo an increase in intracellular Ca 2+, suggesting that activated 
to T-cell activation antigens and also participate in Ca 2+ lymphocytes may be responsive to galectin 3 released from 
signalling, other cell types. 
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2. Materials and methods 
2.1. Antibodies and lectins 
1. Introduction Rat monoclonal ntibody M3/38 against mouse galectin-3 (Mac-2 
antigen) was from Boehringer Mannheim, East Sussex, UK. Polyclo- 
Galectin-3, also called Mac-2 surface differentiation antigen nal rabbit antisera gainst hamster galectin-3 N-terminal and C-termi- 
[1], is a member of a family of mammalian carbohydrate- nal domains were obtained as described [18], and shown by Western 
blotting to cross-react with human galectin-3. Mouse monoclonal 
binding proteins and is expressed widely in epithelial cells antibodies against human CD98 (clone 4F2) and CD1 lb/CDI8 (clone 
and some leukocytes [2,3]. Galectin-3, like other galectin faro- 44) subunits were from PharMingen, Cambridge, UK. Second anti- 
ily members, lacks a signal sequence for import into the bodies and conjugates were from Sigma. Recombinant hamster galec- 
endoplasmic reticulum and is secreted from the cytoplasm tin-3 and the carbohydrate r cognition domain CRD comprising the 
C-terminal half of the lectin were obtained as described [18]. Tetra- 
by a novel mechanism independent of the classical secretary carpidium conophorum agglutinin TCA and its biotinylated derivative 
pathway [4,5]. Secreted galectin-3 binds to appropriately gly- were as described [19]. Griffonia simplicifolia isolectin GSL-IB4, its 
cosylated components of the extracellular matrix such as la- FITC derivative and FITC-labelled streptavidin were from Sigma. 
minin and fibronectin isoforms and to selected cell surface 
glycoproteins [5,6]. 2.2. Cell culture and labelling 
Human Jurkat T cells were grown in suspension cultures at 37°C in 
Galectin-3 is reported to be a signalling molecule. It binds RPMI 1640 medium supplemented with 5% heat-inactivated f tal calf 
to IgE as well as the high affinity IgE receptor on rat baso- serum. For metabolic labelling, cells were washed twice with methio- 
philic leukemia cells and triggers degranulation and serotonin nine-free medium and subsequently cultured for up to 16 h in the 
release [7,8]. In human neutrophils, galectin-3 may play a role same medium supplemented with 200 ~tCi/ml Trans 35S label (Amer- 
sham International, UK). Cells were harvested by centrifugation at
in IgE-mediated activation and stimulates uperoxide produc- 3000xg for 15 min at 2°C. Human monocytic leukemia THP-1 cells 
tion [9]. Galectin-3 also potentiates IL-1 production by human were cultured in RPM1 1640 medium with 15% fetal calf serum and 
monocytes [10]. These results together suggest hat galectin-3 50 nM TPA (12-O-tetradecanoylphorbol-l,3-acetate) at 37°C for 3 
may modulate various inflammatory responses associated with days. 
monocytes/macrophages, mast cells, neutrophils and eosino- 
phils. In this context galectin 3 secretion from different cell 2.3. Affinity chromatography Recombinant hamster galectin-3 was coupled to CNBr-activated 
types including macrophages i increased markedly by heat Sepharose 4B (Pharmacia LKB) in 150 mM lactose-containing buffer 
shock as well as by Ca 2+ ionophores [4,5]. and the product containing approx. 1 mg oflectin per ml of beads was 
Recently we have identified major plasma membrane glyco- packed into a 10 ml column and washed extensively with 8 mM 
CHAPS in 50 mM Tris-HC1 (pH 7.5), 150 mM NaCI, 1 mM proteins recognized by galectin-3 on the mouse WEHI-3 EDTA, 100 IxM leupeptin, 1 ~tM pepstatin, 10 ~tg/ml aprotinin, 1 
macrophage cell line and on thioglycollate-elicited peritoneal mM PMSF (buffer A). Labelled cells (approx. 107) were lysed in 40 
macrophages [11]. These receptors include the c~-subunit of mM CHAPS in buffer A at 2°C and the supernatant (2 ml) after 
CDl lb /CD18 integrin, also known as Mac-1 antigen [12], centrifugation at 100000xg for 1 h was applied to the galectin-3 
and the heavy chain of CD98 recognized by the 4F2 and column. Fractions (2 ml) were eluted first with 8 mM CHAPS-buffer 
A (160 ml) followed by 150 mM lactose-8 mM CHAPS-buffer A (20 
ml). Fractions were analyzed for radioactivity and peak fractions were 
*Corresponding author. Fax: (44) (0181) 913 8595. pooled and concentrated to 2 ml. 
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2.4. Immunoprecipitation andWestern blotting a 
Samples (0.4 ml)of cell lysates or column fractions diluted 1:3 in ~ I' i ~  ]1 
10% Nonidet P40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris-HC1 11 ~ 
(pH 8.0), 150 mM NaC1, 100 JaM leupeptin, 1JaM pepstatin, 10 Jag/ml 84 
aprotinin, 1 mM PMSF (buffer B) were pre-cleared by addition of 
normal rabbit serum (80 Jal) followed by a 50% (w/w) suspension of 56 - 
Protein A-Sepharose in buffer B (50/.tl) and incubation for 2 h at 2°C. 
Cleared supernatants obtained after centrifugation were then treated 28 -~ 
sequentially with various monoclonal antibodies. After addition of 
one primary antibody (1:100 dilution) and incubation overnight at L .. U lilllll IN 
2°C, polyclonal rabbit anti-rat or -mouse lg (1:100 dilution) was I I i ! 
added and immune complexes were collected on Protein A-Sepharose ~ 100 101 102 103 104 
(50 Jal) after 2 h at 2°C. The beads were washed five times with buffer 
B, once with 50 mM Tris pH 8.0 and immune complexes were dis- t-" 
solved in 100 Jal of Laemmli buffer [20] for SDS-7.5% PAGE under :~ b 
reducing or non-reducing conditions. Bands were located by fluoro- O [ J l l J ,  
graphy. In other experiments, Western blotting of cell lysates was Q)  
l A 
performed as described [6]. 60 
2.5. Flow cytometry 40 
Cells were washed and suspended in PBS, 0.1% BSA, 0.1% 
NaN3(PAB) and incubated with monoclonal antibody at saturating 20 
concentrations (10 jag/ml) at 2°C for 30 min. Incubation with FITC- 
second antibody diluted 1:30 in PAB was for 30 min. The cells were . . . . . . .  
again washed in PAB and analyzed by a FACStar P~ (Becton-Dick- I 
inson) after fixation in 1% paraformaldehyde-PBS for 10 min. In 100 101 102 103 104 
other experiments cells were treated with FITC-GSL-IB4 or with bio- 
tinylated TCA (each 30 jag/ml in PAB). In the latter case, bound TCA Fluorescence Intensity 
was revealed by incubation with FITC Streptavidin (10 jag/ml in 
PAB). Fig. 1. Flow cytometric analysis of antigen expression on Jurkat 
cells. Cells were reacted with primary monoclonal antibodies fol- 
2.6. Measurement of [Ca2+]i lowed by FITC conjugates of secondary antibodies. (a) Rat mono- 
Cells (106) were loaded in culture medium with the intracellular clonal galectin-3 antibody followed by FITC-anti rat Ig. The results 
fluorescence indicator Indol-AM (1 gM, acetoxymethyl ester, Sigma) of two separate analyses in which staining was performed before 
at 37°C for 30 rain [21]. Cells were washed and re-suspended (5 × 106 (line 1) or after (line 2) exposure of the cells to galectin-3 are shown 
cell/ml) in 10 mM HEPES pH 7.4, 145 mM NaC1, 5 mM KC1, 1 mM superimposed; (b) mouse monoclonal 4F2 antibody followed by 
CaCI~, 0.5 mM MgSO4, 5 mM glucose (buffer C). Ca 2+ mobilization FITC-anti mouse Ig. Relative fluorescence intensity is shown on the 
was measured at 37°C for each sample (0.4 ml) as indicated in Section abscissa and cell number on the ordinate. The vertical line in each 
3 in a Perkin-Elmer Luminescence Spectrometer LS50 using excitation profile indicates the position at which the negative cut-off cursor 
and emission wavelengths of 355 nm and 405/480 rim. Fluorescence was positioned. 
intensities for Ca2+-saturated and Ca2+-free dye, respectively, were 
determined by lysing the cells with 0.1% Triton X-100 in buffer C 
followed by addition of 10 mM EGTA and 400 mM Tris to the lysed 
cell suspension. Galectin-3 at various final concentrations was added findings were obtained using rabbit polyclonal antibodies 
to cells after 1.5 min of continuous recording when the fluorescence [18] against hamster galectin-3 (results not shown). Western 
signal had stabilized. In other experiments, Indo 1-AM-loaded cells blotting of cell lysates confirmed that Jurkat cells produce no 
were washed and resuspended in Ca2+-free buffer C or were treated 
with various concentrations of diltiazem, nifedipine or prenylamine galectin-3 (Fig. 2). As positive control we used human mono- 
(Sigma) in Ca2+-containing buffer C for 2 min at 37°C before addition cytic cells THP-1 that express low but detectable l vels after 
of galectin-3 (40 gg/ml). Other cell aliquots (10 6) were cultured in TPA treatment (Fig. 2). 
medium containing pertussis toxin or cholera toxin at 37°C for 16 
or 3 h, respectively. The cells were then loaded with Indo 1-AM 
and treated with galectin-3 (40 jag/ml). 3.2. Jurkat cells express urface receptors for galectin-3 
When viable Jurkat cells were treated for 30 min at 37°C 
with exogenous galectin-3 (30 gg/ml), washed and stained with 
3. Results and iscussion the M3138 monoclonal antibody to reveal surface bound lec- 
tin, over 99% of the cells were intensely labelled (Fig. la, line 
3.1. Jurkat T cells do not express galectin-3 2). Binding of the lectin to the cells was blocked completely by 
No surface expression of galectin-3 was found in Jurkat 0.2 M lactose or thiodigalactoside (results not shown), two 
cells by flow cytometry using the rat M3/38 monoclonal anti- inhibitory sugars of galectin-3 binding to model glycoprotein 
body raised against mouse lectin (Fig. la, line 1). Similar ligands [6]. 
We assessed next whether CD98 antigen was one of the 
Table 1 surface components of Jurkat cells recognized by galectin-3, 
Effects of inhibitors on [Ca2+]t fluxes induced by galectin-3 as it is in macrophages [11]. Jurkat cells are known to produce 
CD98 [22,23] and also to express CD98 at the cell surface as 
Inhibitor Maximum inhibition (%) Concentration 
shown by flow cytometry with 4F2 monoclonal antibody (Fig. 
Diltiazem 40 200 jaM lb). Lysates of [35S]methionine-labelled c lls were passed 
Nifedipine 30 100 JaM 
Prenylamine 10 50 gM through a galectin-3-Sepharose affinity column and the bound 
Pertussis toxin 0 150 ng/ml fraction was eluted with lactose. Immunoprecipitation f the 
Cholera toxin 100 50 ng/ml lactose eluate with the 4F2 monoclonal antibody showed the 
Jurkat cells (106) were treated at 37°C for the periods given in Section specific polypeptide pattern expected for CD98 antigen (Fig. 
2 before measurement of [Ca2+]i responses after addition of galectin-3. 3). The ,-, 85 kDa heavy chain and the ,-~ 40 kDa light chain 
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1 2 3 4 Indo-1 and suspended in Ca2+-containing medium showed a 
0 -  3 striking increase of [Ca2+]i following addition of galectin-3 
Mr 1 × . . . . . .  (Fig. 4A). The response was sustained and concentration de- 
: pendent with a half-maximal response at 30 Bg/ml of galectin- 
220  "~ 3 (approx. 1 MM). It clearly required binding of the CRD to 
1 20  ~ cell surface carbohydrates since the [Ca2+]i response was com- 
76  "~ pletely blocked by 200 mM lactose (Fig. 4B) or thiodigalacto- 
66 -~ side (result not shown). Further, the increase in [Ca2+]i n cells 
59  "~ treated with galectin-3 was due to an influx of extracellular 
Ca 2+, and not a release from intracellular stores, as no [Ca2+]i 
increase was detected in Ca')+-free buffers (Fig. 4C). 
43 -~ At sub-micromolar concentrations, galectin-3 appears to be 
33 -~ ,4- monomeric. At higher concentrations chemical and enzymic 
cross-linking experiments [18,24] show that galectin-3 forms 
dimers and possibly higher oligomers and behaves as a multi- 
valent lectin, binding to multiglycosylated ligands with posi- 
tive cooperativity, and showing haemagglutinating activity. 
Fig. 2. Jurkat T-cells do not express galectin-3. Human THP-1 cells Therefore, we tested the effect of polyclonal cross-linking anti- 
(106) treated for 3 days with TPA, or Jurkat T-cells (106-107 cells) bodies on the [Ca2+]i response of cells treated with sub-micro- 
were dissolved in reducing Laemmli buffer, subjected to SDS-PAGE molar concentrations of galectin-3 (20 Bg/ml) However, addi- 
followed by Western blotting with galectin-3 specific monoclonal 
antibody. Note expression of galectin-3 (arrowhead) in THP-1 cells tion of rabbit polyclonal antibodies directed against N- 
treated with TPA (track 1) and no expression in 106 (track 2), terminal or C-terminal domain epitopes of galectin-3 at dilu- 
5x 106 (track 3)or 107 (track 4)Jurkat cells, tions varying from 1:1000 to 1:10 did not induce a [Ca2+]i 
flux greater than that elicited (Fig. 4A) by 20 gg/ml of galec- 
tin-3 alone (results not shown). We conclude that cross-link- 
of CD98 were separated in reducing SDS-PAGE, and in non- ing of cell surface ligands by galectin-3 was not necessary for 
reducing gels the disulphide-bonded heterodimer of '~ 125 signalling. 
kDa was obtained. Other glycoprotein components of the 
bound fraction have not yet been identified, but do not in- 3.4. Specificity of galectin-3-induced [Ca2+]i fluxes 
clude CD1 lb/CD18 (Fig. 3). Several plant lectins are well known to activate lympho- 
cytes, raising the question of the specificity of the galectin 3 
3.3. Galectin-3-induced increase in free cytoplasmic Ca z+ response in Jurkat cells. Therefore, we used two plant lectins 
Jurkat T-cells loaded with the fluorescent Ca 2+ indicator TCA [19] and GSL-IB4 [25], that have overlapping carbohy- 
Reducing Gel Non - Reducing Gel 
I I I i 1 2 3 4 5 6 1 2 3 4 5 6 
Mrx  10 -3 
220 ~ : ~ 
120~ -~ id- 
76 ~ ~ ~ ' *  I~- 
66 ~ 
Fig. 3. CD98 (4F2 antigen) of the Jurkat T-cell line binds galectin-3. [3SS]Methionine-labelled cellswere lysed and fractionated on a galectin-3- 
Sepharose affinity column. Equal portions of total lysate (tracks 1,4) unbound (tracks 2,5) and bound (tracks 3,6) fractions were immunopreci- 
pitated with monoclonal antibodies against human CD1 l b/CD18 (tracks 1-3) followed by 4F2 monoclonal antibody against human CD98 
heavy chain (tracks 4-6). Immune complexes were separated by SDS-PAGE under reducing or non-reducing conditions and proteins located by 
fluorography. The migration of heterodimeric CD98 (open arrowhead), its CD98 heavy and light chains (closed arrowheads) and molecular 
weight markers (arrows) is indicated. 
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Fig. 4. Galectin-3-induced increases in cytosolic [Ca2+]i in Jurkat cells. Cells suspended in buffer containing 1 mM CaCI~ were loaded with 
indo 1-AM and base-line intracellular Ca 2+ levels were recorded fluorimetrically before addition (arrows) of galectin-3. (A) Galectin-3 concen- 
trations: 0 (a), 20 (b), 30 (c), 40 (d), 50 (e) and 60 (f) ~tg/ml, respectively, in Ca2--containing buffer; (B) galectin-3 (40 Ixg/ml) was added alone 
(c) or with 0.2 M lactose (b) in Ca2+-containing buffer. Control without lectin is shown (a). (C) Galectin-3 (40 ~tg/ml) was added to cells sus- 
pended in buffer with (c) or without (b) Ca 2+. Control without lectin in Ca 2+ containing buffer is indicated (a). Calibration was made by Tri- 
ton X-100 release of total cytosolic Ca 2+. Traces were representative of at least three separate experiments. 
drate binding specificities with galectin-3. GSL-IB4 requires (Table 1). Cholera toxin inhibits early events in T-cells follow- 
(z-galactosyl terminal residues as in the human B blood group ing TCR activation, presumably by effects on a pertussis tox- 
epitope to which galectin-3 also binds with high affinity [6 ] ,  in-insensitive G-protein [27]. Further work is required to de- 
and TCA binds to branched complex-type N-glycans with cide whether cholera toxin blockade of the galectin-3-induced 
terminal N-acetyllactosamine units [19]. Flow cytometric ex- [Ca2+]i response occurs similarly. 
periments showed that Jurkat cells carry cell surface receptors 
for GSL-B4 as well as TCA (results not shown). Treatment of 4. Concluding remarks 
Indo 1-AM-loaded Jurkat cells with GSL-IB4 produced a 
slow [Ca2+]i response (Fig. 5A) but only at very high concen- We present data that binding of cell surface glycoproteins 
trations (half maximal response 150/xg/ml). TCA, which is a by galectin-3 leads to increased [Ca2+]i in human Jurkat T 
known T-cell mitogen [19], triggered a [Ca2+]i ncrease at con- cells. Several plant lectins, as well as antibodies to certain T 
centrations 10-fold less than required for galectin-3 (Fig. 5B). cell surface antigens, can stimulate increases in [Ca2+]i. These 
In both cases, the [Ca2+]i response required extracellular Ca 2+ responses are biphasic, consisting of an initial rapid transient 
and was blocked completely in Ca2+-free buffers (results not phase followed by a fall in [Ca2+]i to a sustained plateau level. 
shown). The transient phase increase in [Ca2+]i is due to Cag+-mobi - 
lisation from intracellular stores, triggered by inositol 1,4,5- 
3.5. Inhibitor studies triphosphate (IP3) formation, whereas the sustained increase 
The galectin-3-induced response in [Ca2+]i was not sensitive in [Ca2+]i results from Ca 2+ influx through plasma membrane 
to voltage-gated Ca2+-channel b ockers such as diltiazem or channels [28]. The nature of the extracellular [Ca2+]o-depend- 
nifedipine nor to prenylamine (Table 1), a blocker of an ATP- ent changes in [Ca2+]i are not presently understood and the 
dependent Ca 2+ channel [26], Pertussis toxin had no effect calcium channels in the leukocyte plasma membrane that 
even at very high concentration whereas cholera toxin blocked mediate [Ca2+]o entry have yet to be isolated. Genetic analysis 
the [Ca2+]i response at concentrations lower than 50 ng/ml suggests many gene products are implicated [29]. 
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Fig. 5. Effects of plant lectins GSL-IB4 (A) and TCA (B) on cytosolic [Ca2+]i in Jurkat T-cells. Indo l -AM loaded cells were treated with lec- 
tins and cytosolic [Ca2+]i levels were monitored as described in Fig. 4. (A) Concentrations were 0, 50, 100, 150 and 175 ~tg/ml for a-e, respec- 
tively. (B) Concentrations were 0, 2, 3, 5 ~tg/ml and 7.5 ~tg/ml for a-e, respectively. 
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The results of our studies with galectin-3 lead to the con- [7] Zuberi, R.I., Frigeri, L.G. and Liu, F.-T. (1994) Cell. Immunol. 
clusion that this lectin stimulates Ca2+-channel activity in 156, 1-12. 
plasma membranes. The pattern of effects of a small panel [8] Frigeri, L.G., Zuberi, R.I. and Liu, F.-T. (1993) Biochemistry 32, 
7644-7649. 
of drugs on the galectin-3-induced [Ca2+]i response is identical [9] Yamaoka, A., Kuwabara, I., Frogeri, L.G. and Liu, F.-T. (1995) 
to their effects [30] on Ca 2÷ influx triggered by antibody bind- J. Immunol. 154, 3479-3487. 
ing to the TCR in Jurkat cells. Unfortunately, surface mem- [10] Jeng, K.C., Frigeri, L.G. and Liu, F.-T. (1994) lmmunol. Lett. 
brane Ca2+-channel molecules are not well characterised and 42, 113 116. 
[11] Dong, S. and Hughes, R.C. (1995) Glycoconj. J. 12, 548. 
specific high affinity blockers of their activities are not yet [12] Springer, T.A., Galfre, G., Secher, D.S. and Milstein, C. (1979) 
available to define precisely the target of galectin-3. It seems Eur. J. Immunol. 9, 301 306. 
likely, however, that some of these surface membrane compo- [13] Haynes, B.F., Hemler, M.E., Hann, D.L., Eisenbarth, G.S., Shel- 
nents will carry carbohydrate groups recognized by the lectin, hamer, J., Mostowski, H.S., Strominger, J.L. and Fauci, A.S. 
(1981) J. Immunol. 126, 1409 1414. 
and their ligation may be sufficient o modulate channel ac- [14] Hemler, M.E. and Springer, T.A. (1982) J. Immunol. 129, 623- 
tivity. 628. 
Interestingly, the plant lectin GSL-IB4, that binds well to [15] Bron, C., Rovsseaux, M., Spiazzi, A.-L. and MacDonald, H.R, 
Jurkat cells, induced a slow and reduced Ca 2+ response com- (1986) J. Immunol. 137, 397 399. 
pared with galectin 3. Although GSL-IB4 and galectin-3 show [16] Parmacek, M.S., Karpinski, B.A., Gottesdiener, K.M., Thomp- 
son, C.B. and Leiden, J.M. (1989) Nucleic Acids Res. 17, 1915- 
similar carbohydrate-binding specificities [6,25], there are dif- 1931. 
ferences in detail and it is possible that Jurkat cell surface [17] Foddy, L. Stamatoglou, S.C. and Hughes, R.C. (1990)J. Cell Sci. 
glycoproteins exist that show higher affinity for binding to 97, 139-148. 
galectin-3 compared to GSL-IB4. Characterization of these [18] Mehul, B., Bawumia, S., Martin, S.R. and Hughes, R.C. (1994) 
J. Biol. Chem. 269, 18250-18258. 
glycoproteins will be of interest o identify components likely [19] Sato, S., Animashaun, T. and Hughes, R.C. (1991) J. Biol. Chem. 
to be involved in the galectin-3-induced increase of [Ca2+]i in 266, 11485 11494. 
Jurkat cells. [20] Laemmli, U.K. (1970) Nature 227, 680 685. 
[21] Bijsterbosch, M.K., Rigley, K.P. and Klaus, G.G.B. (1986) Bio- 
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